Navigation Links
SafeShot Technologies Names Dr. Robert W. Beart as New Chief Executive Officer

Company Furthers Innovation and Patent Protection of Epiphany Auto-Retractable, Vacuum Barrel Safety Syringe

Mission Viejo, CA (Vocus) April 21, 2010 -- SafeShot Technologies, LLC, a leader in safety syringe innovation, today announced a new Chief Executive Officer – Dr. Robert W. Beart, Emeritus Professor of Surgery at Keck School of Medicine, University of Southern California. Dr. Beart brings to this position an impressive curriculum vitae in medical innovation and leadership as well as a wealth of experience dealing with the needlestick issue.

The 2008 Study of Nurses Views on Workplace Safety and Needlestick Injuries by the American Nurses Association reveals Needlestick Injuries (NSIs) and blood-borne infections remain a major concern in the U.S., with two-thirds of all nurses having been accidentally stuck by a needle while working. Despite the Needlestick Safety and Prevention Act of 2000, many healthcare professionals ten years later are still not being equipped with safety solutions to eliminate exposure to blood borne pathogens and sharps injuries.

“Throughout my career, I’ve been asked to sit on boards of pharmaceutical companies and biotechnology firms. When I was approached to help SafeShot Technologies take their technology to market in an effort to solve the growing global needlestick issue, which is closely related to the continued rise in infection rate within hospitals, I felt compelled to accept. There is no reason why this issue should continue to persist when an affordable solution has already been discovered. I am excited to advocate for the many healthcare professionals who have been on the other side of a contaminated needle.”

The U.S. General Accounting Office estimated that the annual out-of-pocket costs of treating U.S. hospital needlestick injuries were between $37 million and $173 million. And EcoMed, Inc. reports, globally, 60%-80% needlestick injuries go unreported. “Costs of spring-loaded, retractable safety syringes have limited the adoption of more effective technologies making way into the hospitals and places where shots are administered,” said SafeShot Technologies Co-Founder Dan Thayer. “We are very excited to have Dr. Beart lead the helm in educating the market and helping us put a safer solution in the hands of healthcare professionals on the frontlines.”

“One of the biggest global issues around syringes and the spread of disease is that used disposable syringes are often re-used,” added Dr. Beart. “The issue spans globally and locally, with doctors, surgeons, nurses, sanitation workers and even policemen being exposed on a daily basis to contaminated syringes. It’s estimated that the worldwide market for syringes and needles is estimated to reach 41 billion units in 2012, an annual growth rate of 7%. With more syringes and needles circulating, comes an increase in risk, unless proper technologies are deployed to address the inefficiencies of existing syringes – even those claiming to be safety syringes.”

As the former President of the American Society of Colorectal Surgeons; The Society for Surgery of the Alimentary Tract; and The International Society of University Colorectal Surgeons and Commission on Cancer, Dr. Beart has made significant contributions in his field. He graduated from Harvard Medical School and had his surgical training at the University of Colorado and the Mayo Clinic. He is board certified and recertified in General and Colorectal Surgery. He worked at the Mayo Clinic from 1976 to 1992, where he pioneered the ileal pouch-anal anastomosis procedure, the introduction of stapling devices and the use of laparoscopic surgery for colon resections. He also launched the USC Center for Colorectal Diseases at USC University Hospital and USC/Norris Cancer Center and Hospital.

Dr. Beart is well recognized in the field, having published more than 350 peer reviewed articles, 100 book chapters, and multiple other presentations, movies, and books. He has served as editor-in-chief for Diseases of the Colon and Rectum, and has served on many editorial boards.

About SafeShot Technologies:
SafeShot Technologies, headquartered in Mission Viejo, California, is a new generation safety syringe development company with the mission to solve the needlestick issue with innovative technology. The Epiphany Safety Syringe is the first patented vacuum-triggered, one-handed, single-use, auto-retractable, auto-disable safety syringe designed to provide superior value. There are an estimated 1 million needlestick injuries among 8.8 million workers in the U.S. SafeShot has more than a dozen U.S. patent applications and foreign counterparts in other major jurisdictions to address this growing problem. For more information on SafeShot Technologies and the Epiphany Safety Syringe, please visit

For Additional Information:
Contact: Cathy Sperrazzo, Eye-To-Eye Communications, Inc., 858-565-9800, cathy(at)eyetoeyepr(dot)com


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New research tools for BRAMS via Sonomax Technologies
2. Army Awards Remote Medical Coding Contract to DOMA Technologies
3. Complex Technologies Announces Partnership with 6fusion to Deliver Cloud Services
4. New Vaporizer Technologies Revolutionize Smoking
5. CSMG Technologies, Inc. Engages New Team to Manage Live Tissue Connect, Inc.
6. Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting
7. LifeGuardian Technologies Supports Patients Right to Choose In-Home Care
8. Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors
9. New Application Technologies Keep Herbicides Where They Belong
10. DHS Technologies Unveils New Mobile Vaccination System
11. Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference
Post Your Comments:
Related Image:
SafeShot Technologies Names Dr. Robert W. Beart as New Chief Executive Officer
(Date:10/13/2015)... ... October 13, 2015 , ... Scientists in Seattle and Vancouver compared ... patients with or without mesothelioma. Surviving Mesothelioma has just posted an article on the ... PhenoPath Laboratories in Seattle and the University of British Columbia found that certain genetic ...
(Date:10/13/2015)... ... October 13, 2015 , ... World Patent Marketing , a vertically ... melting invention that helps people in clearing snow away from the streets and driveways. ... at 3.8% per year," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:10/13/2015)... ... October 13, 2015 , ... With Fall weather approaching and holiday travel season ... Facebook Hair Styler Contest. , Enter to win! , How to Enter:, 1. ... Favorite Hair Style? , 3. Follow us on Instagram @thebeautyplace , 4. Share ...
(Date:10/13/2015)... , ... October 13, 2015 , ... Just under three ... customers, eMarketing Concepts began a $1 promotion – effectively offering all of their services ... and within weeks the company was flooded with phone calls from interested buyers. As ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... from GyencoloGeneTM, the world’s first commercially-available next-generation sequencing laboratory test for bacterial ... of Gynecology and Obstetrics in Vancouver, BC, Canada. , In a ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... Corporation (NASDAQ: LMNX ) today announced that it expects ... 2015 on Monday, November 2, 2015. A press release announcing ... trading. --> --> ... highlights and financial results for the third quarter ended September ... time. . Simply log on to ...
(Date:10/12/2015)...  Millions of smokers worldwide have used vaping to ... An April 2015 study released by a ... cigarettes to be up to 95 percent less harmful ... after the technology was first introduced the potentially harmful ... --> --> Palm Beach Vapors, ...
(Date:10/12/2015)...  In a Sutter Institute of Medical Research study ... and Psychiatry, the blood product intravenous immunoglobulin, or IVIG, ... in patients in the early, pre-dementia phase of Alzheimer,s ... IVIG, extracted from the plasma of more than 1,000 ... protein found in patients with Alzheimer,s disease. Sutter Institute ...
Breaking Medicine Technology: